Early hemoglobin decline and survival prognosis in epoetin alfa studies

被引：0
|
作者：
Berlin, J. A.
Bowers, P. J.
Rao, S.
Sun, S.
Liu, K.
Henry, D. H.
机构：
[1] Johnson & Johnson PRD, Titusville, NJ USA
[2] Johnson & Johnson PRD, Raritan, NJ USA
[3] Pennsylvania Oncol Hematol Associates, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9625
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Is Intravenous Ascorbic Acid an Effective And Safe Option for Increasing Hemoglobin Levels in Patients with a Hyporesponse To Epoetin Alfa?
    Kear, Tamara M.
    NEPHROLOGY NURSING JOURNAL, 2012, 39 (02) : 137 - 140
  • [32] Epoetin-alfa/Hemoglobin-glutamerAcute tubular necrosis, hypertension and lack of efficacy: case report
    Reactions Weekly, 2024, 2036 (1) : 182 - 182
  • [33] Efficacy and safety of once-weekly intravenous epoetin alfa in maintaining hemoglobin levels in hemodialysis patients
    Locatelli, Francesco
    Villa, Giuseppe
    Messa, Piergiorgio
    Filippini, Armando
    Cannella, Giuseppe
    De Ferrari, Giacomo
    Naso, Agostino
    Rossi, Egidio
    Formica, Marco
    Lombardi, Luigi
    Rotolo, Ugo
    Conte, Ferruccio
    JOURNAL OF NEPHROLOGY, 2008, 21 (03) : 412 - 420
  • [34] PHARMACOKINETICS AND APPLICATION OF ERYTHROPOIETIN THERAPY - OVERVIEW OF EPOETIN-ALFA STUDIES IN JAPAN
    SHIMOSAKA, A
    MOLECULAR, CELLULAR, AND DEVELOPMENTAL BIOLOGY OF ERYTHROPOIETIN AND ERYTHROPOIESIS, 1994, 718 : 111 - 122
  • [35] Prognostic value of the hemoglobin levels during radiotherapy (RT) in the treatment of esophageal cancer and the impact of epoetin alfa
    Rades, D
    Yekebas, E
    Izbicki, J
    Alberti, W
    Rudat, V
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 116 - 116
  • [36] Hemoglobin responses following darbepoetin alfa (Aranesp®) vs. epoetin alfa (Procrit®) administration in anemic chronic kidney disease (CKD) patients
    Sarac, E
    Veres, Z
    Schuler, E
    Tallum, S
    Gemmel, DJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V264 - V264
  • [37] Better early and overall hematologic outcomes and lower drug cost with epoetin alfa (EPO) compared with darbepoetin alfa (DARB).
    Mark, TL
    McKenzie, SR
    Piech, CT
    BLOOD, 2003, 102 (11) : 510B - 510B
  • [38] Early intervention with epoetin alfa during platinum-based chemotherapy: An analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level
    Savonije, Jorine H.
    van Groeningen, Cees J.
    Wormhoudt, Lars W.
    Giaccone, Guiseppe
    ONCOLOGIST, 2006, 11 (02): : 206 - 216
  • [39] Early results suggest that epoetin alfa 60,000 U every 2 weeks improves hemoglobin in patients with cancer not receiving chemotherapy or radiotherapy
    Shasha, D
    Henry, DH
    Williams, D
    BLOOD, 2004, 104 (11) : 141B - 141B
  • [40] Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy
    Matti S. Aapro
    David C. Dale
    Michael Blasi
    Brenda Sarokhan
    Fawzia Ahmed
    Richard C. Woodman
    Supportive Care in Cancer, 2006, 14 : 1184 - 1194
12345